Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection
Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. // Brain, Behavior, & Immunity - Health. – URL: https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all
Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. Brain, Behavior, & Immunity - Health. https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all
“Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection.” Brain, Behavior, & Immunity - Health.
@article{article8258,
title = {Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection},
journal = {Brain, Behavior, \& Immunity - Health},
url = {https://www.sciencedirect.com/science/article/pii/S2666354626002292?dgcid=rss_sd_all}
}